Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sertraline
- Therapeutic area
- CNS & mental health
- Drug class
- SSRI antidepressants
- ATC
- N06A
- Strength
- 50 mg
- Dosage form
- Tablet
- Pack
- 3 x 10's
- Registration no.
- 104307
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 1,467.30 to 1,539.78 (+4.9%) between 24 Sep 2025 and 17 Aug 2026 · 2 official price records · pack 3 x 10's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Palsiwan 50 mg, 3 x 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/palsiwan-50-mg-104307-3-x-10s-nawan-laboratories-pvt-ltd/ (accessed 23 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 1,539.78 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 1,467.30 | 2025-09-24 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 104307Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
